-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly, Him & Hers Team Up to Broaden Access to Obesity Drugs

MT Newswires·11/06/2026 10:54:03
Listen to the news
10:54 AM EST, 11/06/2026 (MT Newswires) -- Eli Lilly (LLY.F) agreed to expand access to its weight-loss drugs Zepbound and Foundayo through US telehealth company Him & Hers Health's (82W.F) consumer platform. Under the agreement, eligible patients with prescriptions from licensed providers on the platform can access self-pay prices for both drugs and have the medications delivered to their homes, the US pharmaceutical company said Friday.